These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 6663975)

  • 1. [HDL fractions in men with coronary disease and arteriosclerosis obliterans of the lower limbs with normal plasma lipid levels].
    Sznajderman M; Kancelarczyk WL; Rymaszewski Z; Mamont B
    Kardiol Pol; 1983; 26(8-9):623-8. PubMed ID: 6663975
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mortality in men 40 to 59 years old from coronary and cerebral arteriosclerosis with varying cholesterol and triglyceride levels in the blood].
    Nebieridze DV; Zhukovskiĭ GS; Akhmeteli MA; Gerasimova EN; Deev AD
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1981; 4(1):78-81. PubMed ID: 7259871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Spontaneous variations of lipid fractions in normal and hyperlipidemic patients].
    Forti N; Giannini SD; de Góis JM; Dereviacki BE; de Serro-Azul LG
    Arq Bras Cardiol; 1984 Mar; 42(3):177-81. PubMed ID: 6477188
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative study of total cholesterol and its lipoproteic fractions in patients with coronary atherosclerosis, atherosclerosis obliterans and healthy controls in our environment].
    González Juanatey JR; Pose Reino A; Amaro Cendón A; Rubio Alvarez J; Otero Raviña F; Gil de la Peña M; Cabezas-Cerrato J
    Med Clin (Barc); 1985 Sep; 85(7):262-5. PubMed ID: 4058080
    [No Abstract]   [Full Text] [Related]  

  • 5. [Behavior of HDL cholesterol in normal subjects and coronary disease patients: preliminary observations].
    Centonze G; Ciani P; Veglia L
    Boll Soc Ital Cardiol; 1980; 25(3):301-4. PubMed ID: 7284135
    [No Abstract]   [Full Text] [Related]  

  • 6. [HDL lipids in men with obliterating atherosclerosis of the lower extremities (author's transl)].
    Zák A; Zapletalová J; Puchmayer V; Tvrzická E; Skorepa J
    Cas Lek Cesk; 1981 Feb; 120(7):189-93. PubMed ID: 7226186
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of antiatherosclerosis diet with different total caloric value on the level of high density lipoproteins cholesterol in patients with ischemic heart disease].
    Samsonov MA; Frolova IA; Paramonova EG; Zubenko AD; Sirota II
    Vopr Pitan; 1981; (5):15-20. PubMed ID: 7314609
    [No Abstract]   [Full Text] [Related]  

  • 8. Lipoprotein fractions and antithrombin III consumption during clotting.
    Winter JH; Bennett B; McTaggart F; Douglas AS
    Thromb Haemost; 1982 Jun; 47(3):236-8. PubMed ID: 7112497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lipids, high density lipoprotein cholesterol and mortality in coronary and cerebral arteriosclerosis].
    Nebieridze DV; Zhukovskiĭ GS; Deev AD; Akhmeteli MA; Zadoia AA
    Ter Arkh; 1981; 53(1):60-2. PubMed ID: 7221911
    [No Abstract]   [Full Text] [Related]  

  • 10. [The lipoproteic state in patients with coronary heart disease (author's transl)].
    Catalano M; Carzaniga G; Garimoldi M; Sala R; Castelfranco M; Libretti A
    G Ital Cardiol; 1981; 11(12):1944-7. PubMed ID: 7346295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hyperlipoproteinemia, HDL-cholesterol and arteriosclerosis indices].
    Herrmann W; Reuter W
    Z Gesamte Inn Med; 1982 Dec; 37(24):830-3. PubMed ID: 6963524
    [No Abstract]   [Full Text] [Related]  

  • 12. [Various lipoprotein fractions and their relation to ischemic heart disease].
    Palazzuoli V; Mondillo S; Kristodhullu A; De Stefano R; Amatucci G
    G Ital Cardiol; 1983; 13(2):90-4. PubMed ID: 6884650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Does HDL-cholesterol determination facilitate the assessment of risk in coronary patients?].
    Schmid B; Hartmann G
    Schweiz Med Wochenschr; 1983 Dec; 113(50):1923-5. PubMed ID: 6665537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [HDL-cholesterol and family incidence of coronary disease in the Genevan population].
    Suenram A; Pometta D; von der Weid N
    Schweiz Med Wochenschr; 1983 Dec; 113(50):1926-8. PubMed ID: 6665538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The lipid pattern in normals and atherosclerotics.
    Leren P; Haabrekke O
    Acta Med Scand; 1971 Jun; 189(6):495-500. PubMed ID: 5113865
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of Sadamin on lipid metabolism in patients with obliterative arteriosclerosis of lower limbs].
    Kiersnowska B; Bielawiec M; Lukjan H; Grabowski R; Korfel B
    Pol Tyg Lek; 1972 Jan; 27(4):133-5. PubMed ID: 5010169
    [No Abstract]   [Full Text] [Related]  

  • 17. [Blood basocytes in obliterative arteriosclerosis of lower limbs].
    Gonciarz Z
    Pol Tyg Lek; 1967 Sep; 22(39):1480-2. PubMed ID: 6082508
    [No Abstract]   [Full Text] [Related]  

  • 18. [Importance of the determination of HDL-cholesterol in the evaluation of arteriopathies of the lower extremities].
    Arber F; Darioli R; Monti M; Essinger A
    Schweiz Med Wochenschr; 1981 Dec; 111(50):1969-71. PubMed ID: 7330649
    [No Abstract]   [Full Text] [Related]  

  • 19. The peculiarities of lipid and protein components of the high- and low-density lipoproteins in patients suffering from coronary atherosclerosis with different number of affected coronary arteries.
    Gasilin VS; Kurdanov KhA; Perova NV; Torkhovskaya TI; Polessky VA; Matveeva LS
    Cor Vasa; 1981; 23(4):248-56. PubMed ID: 7297073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum HDL-cholesterol, apo-A-I and apo-E levels in patients with abnormal coronary arteries.
    Tan MH; Weldon KL; Albers JJ; Cheung MC; Havel RJ; Vigne JL
    Clin Invest Med; 1980; 3(3-4):225-32. PubMed ID: 6784991
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.